The Trump administration's move to end subsidies for Medicare drug plans could cost consumers

The Trump administration is ending temporary subsidies for Medicare Part D drug plans a year earlier than planned, a move expected to increase premiums for millions of seniors. Officials argue the subsidies are no longer necessary, while policy experts warn of significant cost increases for consumers.